- Home
- OCS vs PHK Comparison
OCS vs PHK Comparison
Compare OCS & PHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- PHK
- Stock Information
- Founded
- OCS 2003
- PHK 2003
- Country
- OCS Switzerland
- PHK United States
- Employees
- OCS N/A
- PHK N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- PHK Finance/Investors Services
- Sector
- OCS Health Care
- PHK Finance
- Exchange
- OCS Nasdaq
- PHK Nasdaq
- Market Cap
- OCS 689.8M
- PHK 769.6M
- IPO Year
- OCS N/A
- PHK N/A
- Fundamental
- Price
- OCS $18.58
- PHK $4.82
- Analyst Decision
- OCS Strong Buy
- PHK
- Analyst Count
- OCS 4
- PHK 0
- Target Price
- OCS $31.50
- PHK N/A
- AVG Volume (30 Days)
- OCS 30.4K
- PHK 491.5K
- Earning Date
- OCS 05-08-2025
- PHK 01-01-0001
- Dividend Yield
- OCS N/A
- PHK 12.61%
- EPS Growth
- OCS N/A
- PHK N/A
- EPS
- OCS N/A
- PHK N/A
- Revenue
- OCS $847,333.00
- PHK N/A
- Revenue This Year
- OCS $49.27
- PHK N/A
- Revenue Next Year
- OCS $1,920.31
- PHK N/A
- P/E Ratio
- OCS N/A
- PHK N/A
- Revenue Growth
- OCS N/A
- PHK N/A
- 52 Week Low
- OCS $10.79
- PHK $4.13
- 52 Week High
- OCS $23.08
- PHK $5.15
- Technical
- Relative Strength Index (RSI)
- OCS 54.68
- PHK 59.85
- Support Level
- OCS $18.01
- PHK $4.53
- Resistance Level
- OCS $19.50
- PHK $4.80
- Average True Range (ATR)
- OCS 0.77
- PHK 0.05
- MACD
- OCS 0.17
- PHK 0.02
- Stochastic Oscillator
- OCS 66.30
- PHK 99.64
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.